Uterine Carcinosarcoma with Alpha-Fetoprotein-Producing Hepatoid Component: A Case Report and Literature Review

A 67-year-old woman presented with postmenopausal vaginal bleeding. Full body imaging demonstrated an intrauterine mass with deep myometrial invasion but no nodal or other metastatic disease. Uterine curettage was performed. Histologically, the tumor was an endometrioid adenocarcinoma with sarcomato...

Full description

Saved in:
Bibliographic Details
Main Authors: Joshua J. X. Li, Jacqueline H. S. Lee, Vicky T. C. Chan, Mei-yung Yu
Format: Article
Language:English
Published: Wiley 2018-01-01
Series:Case Reports in Pathology
Online Access:http://dx.doi.org/10.1155/2018/3972353
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849473227178377216
author Joshua J. X. Li
Jacqueline H. S. Lee
Vicky T. C. Chan
Mei-yung Yu
author_facet Joshua J. X. Li
Jacqueline H. S. Lee
Vicky T. C. Chan
Mei-yung Yu
author_sort Joshua J. X. Li
collection DOAJ
description A 67-year-old woman presented with postmenopausal vaginal bleeding. Full body imaging demonstrated an intrauterine mass with deep myometrial invasion but no nodal or other metastatic disease. Uterine curettage was performed. Histologically, the tumor was an endometrioid adenocarcinoma with sarcomatous element and a hepatoid component, the latter was immunohistochemically positive for alpha-fetoprotein, HepPar-1, and arginase-1. The patient underwent total abdominal hysterectomy and bilateral salpingo-oophorectomy. Serum alpha-fetoprotein level decreased from 31896 ug/l preoperatively to 2063 ug/l postoperatively. Eight weeks later, a rise in serum alpha-fetoprotein was detected, and a biopsy-proven vaginal recurrence was diagnosed. Palliative chemotherapy led to tumor shrinkage and a concurrent decrease in the serum alpha-fetoprotein level. A rise in serum alpha-fetoprotein, refractory to second-line chemotherapy, was accompanied by subsequent development of ureteric obstruction, ascites, and radiological evidence of peritoneal metastases. This is an unusual case of uterine carcinosarcoma with an alpha-fetoprotein-producing hepatoid adenocarcinoma component. Serum alpha-fetoprotein level corresponds to disease recurrence and progression.
format Article
id doaj-art-d3ded046a6934bbfa782132d8be7c3ae
institution Kabale University
issn 2090-6781
2090-679X
language English
publishDate 2018-01-01
publisher Wiley
record_format Article
series Case Reports in Pathology
spelling doaj-art-d3ded046a6934bbfa782132d8be7c3ae2025-08-20T03:24:12ZengWileyCase Reports in Pathology2090-67812090-679X2018-01-01201810.1155/2018/39723533972353Uterine Carcinosarcoma with Alpha-Fetoprotein-Producing Hepatoid Component: A Case Report and Literature ReviewJoshua J. X. Li0Jacqueline H. S. Lee1Vicky T. C. Chan2Mei-yung Yu3Department of Anatomical and Cellular Pathology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong KongDepartment of Obstetrics and Gynaecology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong KongDepartment of Clinical Oncology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong KongDepartment of Anatomical and Cellular Pathology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong KongA 67-year-old woman presented with postmenopausal vaginal bleeding. Full body imaging demonstrated an intrauterine mass with deep myometrial invasion but no nodal or other metastatic disease. Uterine curettage was performed. Histologically, the tumor was an endometrioid adenocarcinoma with sarcomatous element and a hepatoid component, the latter was immunohistochemically positive for alpha-fetoprotein, HepPar-1, and arginase-1. The patient underwent total abdominal hysterectomy and bilateral salpingo-oophorectomy. Serum alpha-fetoprotein level decreased from 31896 ug/l preoperatively to 2063 ug/l postoperatively. Eight weeks later, a rise in serum alpha-fetoprotein was detected, and a biopsy-proven vaginal recurrence was diagnosed. Palliative chemotherapy led to tumor shrinkage and a concurrent decrease in the serum alpha-fetoprotein level. A rise in serum alpha-fetoprotein, refractory to second-line chemotherapy, was accompanied by subsequent development of ureteric obstruction, ascites, and radiological evidence of peritoneal metastases. This is an unusual case of uterine carcinosarcoma with an alpha-fetoprotein-producing hepatoid adenocarcinoma component. Serum alpha-fetoprotein level corresponds to disease recurrence and progression.http://dx.doi.org/10.1155/2018/3972353
spellingShingle Joshua J. X. Li
Jacqueline H. S. Lee
Vicky T. C. Chan
Mei-yung Yu
Uterine Carcinosarcoma with Alpha-Fetoprotein-Producing Hepatoid Component: A Case Report and Literature Review
Case Reports in Pathology
title Uterine Carcinosarcoma with Alpha-Fetoprotein-Producing Hepatoid Component: A Case Report and Literature Review
title_full Uterine Carcinosarcoma with Alpha-Fetoprotein-Producing Hepatoid Component: A Case Report and Literature Review
title_fullStr Uterine Carcinosarcoma with Alpha-Fetoprotein-Producing Hepatoid Component: A Case Report and Literature Review
title_full_unstemmed Uterine Carcinosarcoma with Alpha-Fetoprotein-Producing Hepatoid Component: A Case Report and Literature Review
title_short Uterine Carcinosarcoma with Alpha-Fetoprotein-Producing Hepatoid Component: A Case Report and Literature Review
title_sort uterine carcinosarcoma with alpha fetoprotein producing hepatoid component a case report and literature review
url http://dx.doi.org/10.1155/2018/3972353
work_keys_str_mv AT joshuajxli uterinecarcinosarcomawithalphafetoproteinproducinghepatoidcomponentacasereportandliteraturereview
AT jacquelinehslee uterinecarcinosarcomawithalphafetoproteinproducinghepatoidcomponentacasereportandliteraturereview
AT vickytcchan uterinecarcinosarcomawithalphafetoproteinproducinghepatoidcomponentacasereportandliteraturereview
AT meiyungyu uterinecarcinosarcomawithalphafetoproteinproducinghepatoidcomponentacasereportandliteraturereview